SeekingAlpha · Aug 7, 2026
CR
NASDAQ · CRON
Cronos Group Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$3.31
Up+$0.09 (+2.80%)
Updated Aug 22, 2026, 11:06 AM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.09B
- P/E ratio
- 59.51
- Dividend yield
- 0.00%
- 52-week range
- $2.38 – $3.31
- Volume
- 1.31M
- Avg. volume
- 1.99M
Price performance
CRON price history
1M range · 21 trading sessions · Daily adjusted prices
CRON closed at $3.31 after 21 trading sessions, up 17.79% for the selected period.
- Last close
- $3.31
- Period change
- +17.79%
- Period low
- $2.72
- Period high
- $3.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $3.23 | $3.32 | $3.22 | $3.31 | 1.31M |
| Aug 20, 2026 | $3.275 | $3.299 | $3.21 | $3.22 | 998.13K |
| Aug 19, 2026 | $3.21 | $3.30 | $3.21 | $3.29 | 1.38M |
| Aug 18, 2026 | $3.14 | $3.24 | $3.13 | $3.21 | 1.05M |
| Aug 17, 2026 | $3.14 | $3.18 | $3.12 | $3.15 | 1.33M |
| Aug 14, 2026 | $3.15 | $3.16 | $3.045 | $3.14 | 1.03M |
| Aug 13, 2026 | $3.17 | $3.31 | $3.15 | $3.16 | 1.51M |
| Aug 12, 2026 | $3.06 | $3.175 | $3.04 | $3.17 | 2.05M |
| Aug 11, 2026 | $3.04 | $3.09 | $3.01 | $3.08 | 1.21M |
| Aug 10, 2026 | $3.08 | $3.11 | $2.99 | $3.00 | 1.66M |
| Aug 7, 2026 | $3.13 | $3.17 | $3.065 | $3.10 | 2.09M |
| Aug 6, 2026 | $3.02 | $3.12 | $2.902 | $3.07 | 5.7M |
| Aug 5, 2026 | $2.81 | $2.81 | $2.685 | $2.72 | 1.72M |
| Aug 4, 2026 | $2.84 | $2.865 | $2.79 | $2.81 | 1.4M |
| Aug 3, 2026 | $2.84 | $2.89 | $2.82 | $2.83 | 901.67K |
| Jul 31, 2026 | $2.89 | $2.90 | $2.81 | $2.83 | 728.46K |
| Jul 30, 2026 | $2.87 | $2.91 | $2.855 | $2.89 | 822.81K |
| Jul 29, 2026 | $2.85 | $2.879 | $2.825 | $2.86 | 1.06M |
| Jul 28, 2026 | $2.85 | $2.87 | $2.83 | $2.85 | 828.16K |
| Jul 27, 2026 | $2.82 | $2.88 | $2.76 | $2.86 | 1.07M |
| Jul 24, 2026 | $2.75 | $2.84 | $2.74 | $2.81 | 1.22M |
Latest CRON news
The latest Smart Investors Daily articles mentioning CRON.
Stock researchCompany · Overview
CRON research
Overview
Company profile and research snapshot.
Company profile
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $3.43
- Implied upside
- —
- Analysts
- 7
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 11, 2026 | CANACCORD GENUITY | Buy | — |
| May 10, 2026 | TD COWEN | Buy | — |
| May 10, 2026 | ROTH CAPITAL PARTNERS | Buy | — |
| Mar 1, 2026 | TD COWEN | Buy | — |
| Feb 27, 2026 | ROTH CAPITAL PARTNERS | Buy | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 7, 2026
Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A
Cronos Group (CRON) expands in Europe via CanAdelaar as revenue jumps 58% YoY. Click here to read my most recent analysis of CRON stock.
SeekingAlpha · Aug 6, 2026
Cronos Group Inc. (CRON:CA) Q2 2026 Earnings Call Transcript
Cronos Group Inc. (CRON:CA) Q2 2026 Earnings Call August 6, 2026 8:30 AM EDTCompany ParticipantsHarrison AaronMichael Gorenstein - President, CEO &...
Benzinga · Aug 6, 2026
Cronos Group Q2 EPS $0.09 Beats $0.01 Estimate, Sales $53.007M Beat $44.200M Estimate
Cronos Group (TSX:CRON) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.01 by 800 percent. This is a 190 percent increase over losses of $(0.10) per share from the same
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
